2.4 semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Novo Nordisk study finds greater

1993), and thrombin activation of the anticoagulant thrombomodulin/protein C process (Rodgers and Conn, 1990)

Even people who achieve the treatment goals with the new obesity pharmacotherapies might decide to undergo bariatric surgery to support long-term weight maintenance because either they experience weight regain on the medication or they do not have long-term access to obesity pharmacotherapy, or they prefer not to take obesity pharmacotherapy lifelong

[32] found that ethanol-induced fatty liver and cirrhosis in wild-type and humanized CYP2E1 knock-in mice but attenuated ethanol-induced fatty liver in CYP2E1 knockout mice

10.1038/s41591-019-0375-9 Nat